1-year weight change after diabetes diagnosis and long-term incidence and sustainability of remission of type 2 diabetes in real-world settings in Hong Kong: An observational cohort study

In this population based cohort study of >37,000 people in Hong Kong, Hongjiang Wu and colleagues examine 1-year weight change after diabetes diagnosis with long-term incidence and sustainability of diabetes remission.

Related Keywords

Hong Kong ,Vienna ,Wien ,Austria ,University Of Hong Kong ,Hong Kong General ,Shanghai ,China ,Eli Lilly ,Merck Serono ,Junshi Biosciences ,Astra Zeneca ,Daiichi Sankyo ,Hospital Authority ,Pfizer ,Nestle ,Amgen ,Tricida Inc ,Management Programme For Diabetes Mellitus ,International Consensus ,Hong Kong Hospital Authority ,Novo Nordisk ,Chinese University Of Hong Kong ,Astrazeneca ,Boehringer Ingelheim ,R Foundation For Statistical Computing ,Risk Assessment ,Management Programme ,Diabetes Mellitus ,Creative Commons Attribution License ,Hong Kong Hospital ,Lee Pharmaceutical ,Shanghai Junshi Biosciences ,Applied Therapeutics ,Hua Medicine ,Lee Powder ,Merck Sharp ,Kyowa Kirin ,Roche Diagnostics ,Chinese University ,Diabetes Remission Clinical Trial ,Electronic Medical Record ,Hong Kong Chinese ,Observational Studies ,Statistical Computing ,Body Weight ,Weight Loss ,Diabetes Diagnosis And Management ,Hba1c ,Type 2 Diabetes ,Epidemiology ,Weight Gain ,